Ghana Pharmaceuticals and Healthcare Report Q2 2016
BMI View: The Ghanaian government is actively making progress towards fulfilling its ambition of being
the Economic Communities of West African States (ECOWAS) hub for pharmaceutical and healthcare
investment. Domestic drugmakers are in a favourable position to take advantage of the growing regional
demand for medicines, while the government, in association with foreign aid agencies, is continuing to
upgrade local export capacities. The larger domestic manufacturers will look to gain WHO certification
and fulfilment of export potential needs for Good Manufacturing Practice certification. This would allow
Ghana to reduce its unsustainable reliance on imported pharmaceuticals, however cheaper generic imports
threaten the competitiveness of Ghanaian domestic drug manufacturers on a domestic and regional scale.
Headline Expenditure Projections
Pharmaceuticals: GHS1.18bn (USD311mn) in 2015 to GHS1.37bn (USD340mn) in 2016; +16.3% in local
currency terms and +9.5% in US dollar terms. Forecast unchanged from Q116.
Healthcare: GHS6.60bn (USD1.74bn) in 2015 to GHS7.47bn (USD1.86bn) in 2016; +13.3% in local
currency terms and +6.6% in US dollar terms. Forecast in line with Q415.
BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Ghana 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ghana 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 25
OTC Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Ghana 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Ghana 2014-2020) 31
Industry Risk/Reward Index 32
Middle East and Africa Risk/Reward Index - Q2 2016 32
Ghana Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 42
Intellectual Property Issues 43
Pricing And Reimbursement Regime 44
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Ghana 2010-2015) 51
Table: Healthcare Personnel (Ghana 2010-2015) 51
Table: Healthcare Activity (Ghana 2010-2015) 52
Research & Development 52
Clinical Trials 52
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Generic Drugmakers 60
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 61
Company Profile 62
Ayrton Drug Manufacturing Company (Adcock Ingram) 62
Danadams 65
Demographic Forecast 69
Table: Population Headline Indicators (Ghana 1990-2025) 70
Table: Key Population Ratios (Ghana 1990-2025) 70
Table: Urban/Rural Population & Life Expectancy (Ghana 1990-2025) 71
Table: Population By Age Group (Ghana 1990-2025) 71
Table: Population By Age Group % (Ghana 1990-2025) 72
Glossary 74
Methodology 76
Pharmaceutical Expenditure Forecast Model 76
Healthcare Expenditure Forecast Model 76
Notes On Methodology 77
Risk/Reward Index Methodology 78
Index Overview 79
Table: Pharmaceutical Risk/Reward Index Indicators 79
Indicator Weightings 80
List of Tables
Table: Headline Pharmaceuticals & Healthcare Forecasts (Ghana 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ghana 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ghana 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Ghana 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Ghana 2014-2020)
Table: Healthcare Resources (Ghana 2010-2015)
Table: Healthcare Personnel (Ghana 2010-2015)
Table: Healthcare Activity (Ghana 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Ghana 1990-2025)
Table: Key Population Ratios (Ghana 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Ghana 1990-2025)
Table: Population By Age Group (Ghana 1990-2025)
Table: Population By Age Group % (Ghana 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators